 REDWOOD CITY, Calif., June 14, 2021 PRNewswire -- Nevro Corp. NYSE: NVRO, a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, today announced it will host an analyst investor briefing from the American Diabetes Association 81st Scientific Sessions on Friday, June 25, 2021, beginning at 3:30 pm PT 6:30 pm ET. 